We checked this association in additional TCGA breast cancer samples (which does not have chromatin accessible data) and found that the expression of BMPR1B was significantly lower in mutant p53 samples (Wilcoxon rank-sum test, P = 2 × 10− 14) (Fig. 4e). The gene discussed is TP53; the disease is breast carcinoma.